Just published: “Challenges of cost-effectiveness analyses of novel therapeutic…
[ad_1]
Just published: https://t.co/J6DVFiHmqX “Challenges of cost-effectiveness analyses of novel therapeutics for Inherited Retinal Diseases”
While the current #healthcare system may appropriately value chronically administered therapies, it may not properly appraise #GeneTherapy… https://t.co/5qedMXTz9f
[ad_2]
Source by Thomas Ciulla, MD, MBA